Vaccination in adults with auto-immune disease and/or drug related immune deficiency: Results of the GEVACCIM Delphi survey

Vaccine

Volumn 27, Issue 10, 2009, Pages 1523-1529

  Duchet Niedziolka, P ^a   Launay, O ^a   Coutsinos, Z ^a   Ajana, F ^b   Arlet, P ^c   Barrou, B ^d   Beytout, J ^e   Bouchaud, O ^f   Brouqui, P ^g   Buzyn, A ^h   Chidiac, C ⁱ   Couderc, L J ^j   Debord, T ^k   Dellamonica, P ^l   Dhote, R ^m   Duboust, A ⁿ   Durrbach, A ^o   Fain, O ^p   Fior, R ^d   Godeau, B ^d   Goujard, C ^q   Hachulla, E ^r   Marchou, B ^s   Mariette, X ^t   May, T ^u   Meyer, O ^v   Milpied, N ^w   Morlat, P ^x   Pouchot, J ^y   Tattevin, P ^z   Viard, J P ^h   Lortholary, O ^h   Hanslik, T ^o,aa   more..

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b CENTRE HOSPITALIER DE TOURCOING   (France)

^c Serv Univ Psychiat l'Enfant l'A   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^f UNIVERSITÉ PARIS 13   (France)

^g ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^h HÔPITAL NECKER ENFANTS MALADES   (France)

ⁱ CROIX ROUSSE HOSPITAL   (France)

^j FOCH HOSPITAL   (France)

^k SERVICE D ENDOCRINOLOGIE   (France)

^l UNIVERSITÉ CÔTE D'AZUR   (France)

^m AVICENNE HOSPITAL   (France)

ⁿ SAINT LOUIS HOSPITAL   (France)

^o INSERM   (France)

^p HÔPITAL JEAN VERDIER   (France)

^q BICÊTRE HOSPITAL   (France)

^r LILLE UNIVERSITY HOSPITAL   (France)

^s CHU PURPAN   (France)

^t UNIVERSITÉ PARIS SACLAY   (France)

^u CHU NANCY BRABOIS   (France)

^v BICHAT HOSPITAL   (France)

^w BORDEAUX UNIVERSITY HOSPITAL   (France)

^x UNIVERSITÉ DE BORDEAUX   (France)

^y HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^z PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^aa HÔPITAL AMBROISE PARÉ   (France)

more..

Author keywords

Auto immune disease; Delphi survey; Immunocompromised adults; Immunosuppressants; Vaccination

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DIPHTHERIA VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; LIVE VACCINE; MENINGOCOCCUS VACCINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; PREDNISONE; RABIES VACCINE; RUBELLA VACCINE; TETANUS TOXOID; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; YELLOW FEVER VACCINE;

ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DECISION MAKING; DIPHTHERIA; DRUG INDUCED DISEASE; HEALTH SURVEY; HEPATITIS A; HEPATITIS B; HUMAN; IMMUNE DEFICIENCY; INFLUENZA; MENINGOCOCCOSIS; PATIENT MONITORING; PNEUMOCOCCAL INFECTION; POLIOMYELITIS; PRESCRIPTION; PRIORITY JOURNAL; RABIES; RELAPSE; RISK ASSESSMENT; RUBELLA; TETANUS; TREATMENT DURATION; VACCINATION; YELLOW FEVER;

EID: 60749099025     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.01.003     Document Type: Article

References (73)

1. Armstrong D. Empiric therapy for the immunocompromised host. Rev Infect Dis 13 Suppl. 9 (1991) S763-S769
2. Beck J.M. The immunocompromised host: HIV infection. Proc Am Thorac Soc 2 (2005) 423-427
3. Rubin R.H., Schaffner A., and Speich R. Introduction to the Immunocompromised Host Society consensus conference on epidemiology, prevention, diagnosis, and management of infections in solid-organ transplant patients. Clin Infect Dis 33 Suppl. 1 (2001) S1-4
4. Risi G.F., and Tomascak V. Prevention of infection in the immunocompromised host. Am J Infect Control 26 (1998) 594-604
5. Petri M. Infection in systemic lupus erythematosus. Rheum Dis Clin North Am 24 (1998) 423-456
6. Bouza E., Moya J.G., and Muñoz P. Infections in systemic lupus erythematosus and rheumatoid arthritis. Infect Dis Clin North Am 15 (2001) 335-361
7. Yéni P, editor. Prise en charge médicale des personnes infectées par le VIH. Recommandations du groupe d'experts. Rapport 2006. Paris: Médecine Sciences, Flammarion 2006.
8. Comité Technique des Vaccinations, Section Maladies Transmissibles du Conseil Supérieur d'Hygiène Publique de France. Guide des vaccinations 2006. www.inpes.sante.fr/CFESBases/catalogue/pdf/927.pdf.
9. Stark K., Gunther M., Schonfeld C., Tullius S.G., and Bienzle U. Immunisations in solid-organ transplant recipients. Lancet 359 (2002) 957-965
10. Mileno M.D., and Bia F.J. The compromised traveller. Infect Dis Clin North Am 12 (1998) 369-412
11. Duchet Niedziolka P., Launay O., Salmon Ceron D., Consigny P.H., Ancelle T., Van der Vliet D., et al. pour le groupe GEVACCIM. Antiviral immunization of immunocompromised adults, literature review. Rev Med Interne (2007 September 21) [Epub ahead of print]
12. Wraith D.C., Goldman M., and Lambert P.H. Vaccination and autoimmune disease: what is the evidence?. Lancet 362 (2003) 1659-1666
13. Bridges M.J., Coady D., Kelly C.A., Hamilton J., and Heycock C. Factors influencing uptake of influenza vaccination in patients with rheumatoid arthritis. Ann Rheum Dis 62 (2003) 685
14. Hanslik T., Wechsler B., Vaillant J.N., Audrain L., Prinseau J., Baglin A., et al. A survey of physicians' vaccine risk perception and immunization practices for subjects with immunological diseases. Vaccine 19 (2000) 908-915
15. Hanslik T., Valleron A.J., and Flahault A. Risk-benefit assessment of hepatitis B vaccination in France, 2006. Rev Med Interne 27 (2006) 40-45
16. Hanslik T., Boulard J.C., and Baglin A. Vaccination and immunologic diseases. Rev Med Interne 17 (1996) 17-20
17. Hasson F., Keeney S., and McKenna H. Research guidelines for the Delphi survey technique. J Adv Nurs 32 4 (2000 October) 1008-1015
18. Centers for Disease Control and Prevention (CDC). Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Recommendations of CDC, the Infectious Disease society of America, and the American Society of blood and Marrow Transplantation. MMWR Morb Mortal Wkly Rep 49 RR-10 (2000) 1-125
19. Ljungman P., Engelhard D., de la Cámara R., Einsele H., Locasciulli A., Martino R., et al. Infectious diseases working party of the european group for blood and marrow transplantation. Bone Marrow Transplant 35 (2005) 737-746
20. Comité Technique des Vaccinations, section Maladies Transmissibles du Conseil Supérieur d'Hygiène Publique de France. Calendrier vaccinal 2006. BEH 2006; 29-30:211-26.
21. Holvast B., Huckriede A.L., Wilschut J., Horst G., De Vries J.J., Benne C.A., et al. Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease. Ann Rheum Dis 65 (2006) 913-918
22. Mercado U., Acosta H., and Avendano L. Influenza vaccination of patients with systemic lupus erythematosus. Rev Invest Clin 56 (2004) 16-20
23. Abu-Shakra M., Press J., Varsano N., Levy V., Mendelson E., Sukenik S., et al. Specific antibody response after influenza immunization in systemic lupus erythematosus. J Rheumatol 29 (2002) 2555-2557
24. Abu-Shakra M., Zalmanson S., Neumann L., Flusser D., Sukenik S., and Buskila D. Influenza virus vaccination of patients with systemic lupus erythematosus: effects on disease activity. J Rheumatol 27 (2000) 1681-1685
25. Turner-Stokes L., and Isenberg D.A. Immunisation of patients with rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 47 (1988) 529-531
26. Brodman R., Gilfillan R., Glass D., and Schur P.H. Influenzal vaccine response in systemic lupus erythematosus. Ann Intern Med 88 (1978) 735-740
27. Ristow S.C., Douglas RGJr, and Condemi J.J. Influenza vaccination of patients with systemic lupus erythematosus. Ann Intern Med 88 (1978) 786-789
28. Louie J.S., Nies K.M., Shoji K.T., Fraback R.C., Abrass C., Border W., et al. Clinical and antibody responses after influenza immunization in systemic lupus erythematosus. Ann Intern Med 88 (1978) 790-792
29. Elkayam O., Paran D., Burke M., Zakut V., Ben-Yitshak R., Litinsky I., et al. Pneumococcal vaccination of patients with systemic lupus erythematosus: effects on generation of autoantibodies. Autoimmunity 38 (2005) 493-496
30. Mercado U. Antibody response to influenza immunization in patients with systemic lupus erythematosus. J Rheumatol 30 (2003) 2295 [author reply 2295-6]
31. Elkayam O., Paran D., Caspi D., Litinsky I., Yaron M., Charboneau D., et al. Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus. Clin Infect Dis 34 (2002) 147-153
32. Tarjan P., Sipka S., Marodi L., Nemes E., Lakos G., Gyimesi E., et al. No short-term immunological effects of Pneumococcus vaccination in patients with systemic lupus erythematosus. Scand J Rheumatol 31 (2002) 211-215
33. Battafarano D.F., Battafarano N.J., Larsen L., Dyer P.D., Older S.A., Muehlbauer S., et al. Antigen-specific antibody responses in lupus patients following immunization. Arthritis Rheum 41 (1998) 1828-1834
34. McDonald E., Jarrett M.P., Schiffman G., and Grayzel A.I. Persistence of pneumococcal antibodies after immunization in patients with systemic lupus erythematosus. J Rheumatol 11 (1984) 306-308
35. Jarrett M.P., Schiffman G., and Barland P. Impaired response to pneumococcal vaccine in systemic lupus erythematosus. Arthritis Rheum 23 (1980) 1278-1293
36. Schattner A., Ben-Chetrit E., and Schmilovitz H. Poliovaccines and the course of systemic lupus erythematosus-a retrospective study of 73 patients. Vaccine 10 (1992) 98-100
37. Gartner S., and Emlen W. Hepatitis B vaccination of SLE patients [abstracts]. Proceedings of the ACR Congress. Orlando, October 1996. Ann Rheum Dis 39 Suppl. 291 (1996)
38. Erkek E., Ayaslioglu E., Erkek A.B., Kurtipek G.S., and Bagci Y. Response to vaccination against hepatitis B in patients with Behcet's disease. J Gastroenterol Hepatol 20 (2005) 1508-1511
39. Elkayam O., Yaron M., and Caspi D. Safety and efficacy of vaccination against hepatitis B in patients with rheumatoid arthritis. Ann Rheum Dis 61 (2002) 623-625
40. Fomin I., Caspi D., Levy V., Varsano N., Shalev Y., Paran D., et al. Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers. Ann Rheum Dis 65 (2006) 191-194
41. Kapetanovic M.C., Saxne T., Sjoholm A., Truedsson L., Jonsson G., and Geborek P. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology (Oxford) 45 (2006) 9-10
42. Elkayam O., Caspi D., Reitblatt T., Charboneau D., and Rubins J.B. The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum 33 (2004) 283-288
43. Confavreux C., Suissa S., Saddier P., Bourdes V., and Vukusic S. Vaccines in Multiple Sclerosis Study Group. Vaccinations and the risk of relapse in multiple sclerosis. N Engl J Med 344 (2001) 319-326
44. Williams G.W., Steinberg A.D., Reinertsen J.L., Klassen L.W., Decker J.L., and Dolin R. Influenza immunization in systemic lupus erythematosus. A double blind trial. Ann Intern Med 88 (1978) 729-734
45. Lipnick R.N., Karsh J., Stahl N.I., Blackwelder W.C., Schiffman G., and Klippel J.H. Pneumococcal immunization in patients with systemic lupus erythematosus treated with immunosuppressives. J Rheumatol 12 (1985) 1118-1121
46. Klippel J.H., Karsh J., Stahl N.I., Decker J.L., Steinberg A.D., and Schiffman G. A controlled study of pneumococcal polysaccharide vaccine in systemic lupus erythematosus. Arthritis Rheum 22 (1979) 1321-1325
47. Karsh J., Pavlidis N., Schiffman G., and Moutsopoulos H.M. Immunization of patients with Sjogren's syndrome with pneumococcal polysaccharide vaccine: a randomized trial. Arthritis Rheum 23 (1980) 1294-1298
48. Nicholson K.G., Nguyen-Van-Tam J.S., Ahmed A.H., Wiselka M.J., Leese J., Ayres J., et al. Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma. Lancet 351 (1998) 326-331
49. Miller A.E., Morgante L.A., Buchwald L.Y., Nutile S.M., Coyle P.K., Krupp L.B., et al. A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis. Neurology 48 (1997) 312-314
50. British Society for Rheumatology (BSR). Vaccinations in the immunocompromised person: guidelines for the patient taking immunosuppressants, steroids and the new biologic therapies. BSR 2002 http://www.rheumatology.org.uk/guidelines/clinicalguidelines.
51. Atkinson W.L., Pickering L.K., Schwartz B., Weniger B.G., Iskander J.K., and Watson J.C. Centers for Disease Control and Prevention. General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP). MMWR Recomm Rep 51 (2002) 22-23
52. Advisory Committee on Immunization Practices. Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins for persons with altered immunocompetence. MMWR Recomm Rep 42 (1993) 1-18
53. Duchini A., Goss J.A., Karpen S., and Pockros P.J. Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols. Clin Microbiol Rev 16 (2003) 357-364
54. Advisory Committee on Immunization Practices (ACIP), CDC. Prevention of varicella- provisional updated ACIP recommendations for varicella vaccine use. MMWR Recomm Rep (2005)
55. Cetron M.S., Marfin A.A., Julian K.G., Gubler D.J., Sharp D.J., Barwick R.S., et al. Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002. MMWR Recomm Rep 52 (2002) 7-8
56. Watson J.C., Hadler S.C., Dykewicz C.A., Reef S., and Phillips L. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 47 (1998) 21-22
57. Comité Technique des Vaccinations, Section Maladies Transmissibles du Conseil Supérieur d'Hygiène Publique de France. Calendrier vaccinal 2005. BEH 2005; 29-30:142-7.
58. Baumann M.H., Strange C., Heffner J.E., Light R., Kirby T.J., Klein J., et al. Management of spontaneous pneumothorax. Chest 119 (2001) 590-602
59. Keeney S., Hasson F., and McKenna H. Consulting the oracle: ten lessons from using the Delphi technique in nursing research. J Adv Nurs 53 (2006) 205-212
60. Powell C. The Delphi technique: myths and realities. J Adv Nurs 41 (2003) 376-382
61. Kengsakul K., Sathirapongsasuti K., and Punyagupta S. Fatal myeloencephalitis following yellow fever vaccination in case with HIV infection. J Med Assoc Thai 85 (2002) 131-134
62. Schrauder A., Henke-Gendo C., Seidemann K., Sasse M., Cario G., Moericke A., et al. Varicella vaccination in a child with acute lymphoblastic leukaemia. Lancet 369 (2007) 1232
63. Oren S., Mandelboim M., Braun-Moscovici Y., Paran D., Ablin J., Litinsky I., et al. Vaccination against influenza in rheumatoid arthritis patients: the effect of rituximab on the humoral response. Ann Rheum Dis 67 (2008) 937-941
64. Pham T., Claudepierre P., Deprez X., Fautrel B., Goupille P., Hilliquin P., et al. Club Rhumatismes et Inflammation, French Society of Rheumatology. Anti-TNF alpha therapy and safety monitoring. Clinical tool guide elaborated by the Club Rhumatismes et Inflammations (CRI), section of the French Society of Rheumatology (Société Française de Rhumatologie, SFR). Joint Bone Spine 72 Suppl. 1 (2005) S1-58
65. Duchet-Niedziolka P., Coutsinos Z., Hanslik T., and Launay L. Anti-TNFalpha therapy and vaccination of adults. Joint Bone Spine 74 (2007) 563-565
66. Ledingham J., Deighton C., British Society for Rheumatology Standards, and Guidelines and Audit Working Group. Update on the British Society for Rheumatology guidelines for prescribing TNF alpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001). Rheumatology (Oxford) 44 (2005) 157-163 [Erratum in: Rheumatology (Oxford) 2006; 45:1170]
67. Stuck A.E., Minder C.E., and Frey F.J. Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis 11 (1989) 954-963
68. Kim H.A., Yoo C.D., Baek H.J., Lee E.B., Ahn C., Han J.S., et al. Mycobacterium tuberculosis infection in a corticosteroid-treated rheumatic disease patient population. Clin Exp Rheumatol 16 (1998) 9-13
69. Kubiet M.A., Gonzalez-Rothi R.J., Cottey R., and Bender B.S. Serum antibody response to influenza vaccine in pulmonary patients receiving corticosteroids. Chest 110 (1996) 367-370
70. Hanania N.A., Sockrider M., Castro M., Holbrook J.T., Tonascia J., Wise R., et al. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. J Allergy Clin Immunol 113 (2004) 717-724
71. Ministerio de sanidad y consumo. Vacunacion en adultos. Recomendaciones ano 2004. http://www.murciasalud.es/recursos/ficheros/61110-Calendario%20adultos.p df (accessed February 2008).
72. Direcçao geral da saude. Programa nacional de vacinacao 2006. Circular normativa N°08/DT de 21/12/2005. http://www.dgsaude.pt/upload/membro.id/ficheiros/i007442.pdf (accessed February 2008).
73. Comité consultatif de la médecine tropicale et de la médecine des voyages (CCMTMV). Le voyageur immunodéprimé. RMTC 2007; 33(DCC-4):1-24. http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/07pdf/acs33-04.pdf (accessed February 2008).